Cargando…
Post-Mortem Cardiac Magnetic Resonance for the Diagnosis of Hypertrophic Cardiomyopathy
Background: Post-mortem cardiac magnetic resonance (PMCMR) is an emerging tool supporting forensic medicine for the identification of the causes of cardiac death, such as hypertrophic cardiomyopathy (HCM). We proposed a new method of PMCMR to diagnose HCM despite myocardial rigor mortis. Methods: We...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700290/ https://www.ncbi.nlm.nih.gov/pubmed/33233445 http://dx.doi.org/10.3390/diagnostics10110981 |
_version_ | 1783616244718501888 |
---|---|
author | Aquaro, Giovanni Donato Guidi, Benedetta Biondi, Federico Chiti, Enrica Santurro, Alessandro Scopetti, Matteo Turillazzi, Emanuela Di Paolo, Marco |
author_facet | Aquaro, Giovanni Donato Guidi, Benedetta Biondi, Federico Chiti, Enrica Santurro, Alessandro Scopetti, Matteo Turillazzi, Emanuela Di Paolo, Marco |
author_sort | Aquaro, Giovanni Donato |
collection | PubMed |
description | Background: Post-mortem cardiac magnetic resonance (PMCMR) is an emerging tool supporting forensic medicine for the identification of the causes of cardiac death, such as hypertrophic cardiomyopathy (HCM). We proposed a new method of PMCMR to diagnose HCM despite myocardial rigor mortis. Methods: We performed CMR in 49 HCM patients, 30 non-HCM hypertrophy, and 32 healthy controls. In cine images, rigor mortis was simulated by the analysis of the cardiac phase corresponding to 25% of diastole. Left ventricular mass, mean, and standard deviation (SD) of WT, maximal WT, minimal WT, and their difference were compared for the identification of HCM. These parameters were validated at PMCMR, evaluating eight hearts with HCM, 10 with coronary artery disease, and 10 with non-cardiac death. Results: The SD of WT with a cut-off of > 2.4 had the highest accuracy to identify HCM (AUC 0.95, 95% CI = 0.89–0.98). This was particularly evident in the female population of HCM (AUC=0.998), with 100% specificity (95% CI = 85–100%) and 96% sensitivity (95% CI = 79–99%). Using this parameter, at PMCMR, all of the eight patients with HCM were correctly identified with no false positives. Conclusions: PMCMR allows identification of HCM as the cause of sudden death using the SD of WT > 2.4 as the diagnostic parameter. |
format | Online Article Text |
id | pubmed-7700290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77002902020-11-30 Post-Mortem Cardiac Magnetic Resonance for the Diagnosis of Hypertrophic Cardiomyopathy Aquaro, Giovanni Donato Guidi, Benedetta Biondi, Federico Chiti, Enrica Santurro, Alessandro Scopetti, Matteo Turillazzi, Emanuela Di Paolo, Marco Diagnostics (Basel) Article Background: Post-mortem cardiac magnetic resonance (PMCMR) is an emerging tool supporting forensic medicine for the identification of the causes of cardiac death, such as hypertrophic cardiomyopathy (HCM). We proposed a new method of PMCMR to diagnose HCM despite myocardial rigor mortis. Methods: We performed CMR in 49 HCM patients, 30 non-HCM hypertrophy, and 32 healthy controls. In cine images, rigor mortis was simulated by the analysis of the cardiac phase corresponding to 25% of diastole. Left ventricular mass, mean, and standard deviation (SD) of WT, maximal WT, minimal WT, and their difference were compared for the identification of HCM. These parameters were validated at PMCMR, evaluating eight hearts with HCM, 10 with coronary artery disease, and 10 with non-cardiac death. Results: The SD of WT with a cut-off of > 2.4 had the highest accuracy to identify HCM (AUC 0.95, 95% CI = 0.89–0.98). This was particularly evident in the female population of HCM (AUC=0.998), with 100% specificity (95% CI = 85–100%) and 96% sensitivity (95% CI = 79–99%). Using this parameter, at PMCMR, all of the eight patients with HCM were correctly identified with no false positives. Conclusions: PMCMR allows identification of HCM as the cause of sudden death using the SD of WT > 2.4 as the diagnostic parameter. MDPI 2020-11-21 /pmc/articles/PMC7700290/ /pubmed/33233445 http://dx.doi.org/10.3390/diagnostics10110981 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Aquaro, Giovanni Donato Guidi, Benedetta Biondi, Federico Chiti, Enrica Santurro, Alessandro Scopetti, Matteo Turillazzi, Emanuela Di Paolo, Marco Post-Mortem Cardiac Magnetic Resonance for the Diagnosis of Hypertrophic Cardiomyopathy |
title | Post-Mortem Cardiac Magnetic Resonance for the Diagnosis of Hypertrophic Cardiomyopathy |
title_full | Post-Mortem Cardiac Magnetic Resonance for the Diagnosis of Hypertrophic Cardiomyopathy |
title_fullStr | Post-Mortem Cardiac Magnetic Resonance for the Diagnosis of Hypertrophic Cardiomyopathy |
title_full_unstemmed | Post-Mortem Cardiac Magnetic Resonance for the Diagnosis of Hypertrophic Cardiomyopathy |
title_short | Post-Mortem Cardiac Magnetic Resonance for the Diagnosis of Hypertrophic Cardiomyopathy |
title_sort | post-mortem cardiac magnetic resonance for the diagnosis of hypertrophic cardiomyopathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700290/ https://www.ncbi.nlm.nih.gov/pubmed/33233445 http://dx.doi.org/10.3390/diagnostics10110981 |
work_keys_str_mv | AT aquarogiovannidonato postmortemcardiacmagneticresonanceforthediagnosisofhypertrophiccardiomyopathy AT guidibenedetta postmortemcardiacmagneticresonanceforthediagnosisofhypertrophiccardiomyopathy AT biondifederico postmortemcardiacmagneticresonanceforthediagnosisofhypertrophiccardiomyopathy AT chitienrica postmortemcardiacmagneticresonanceforthediagnosisofhypertrophiccardiomyopathy AT santurroalessandro postmortemcardiacmagneticresonanceforthediagnosisofhypertrophiccardiomyopathy AT scopettimatteo postmortemcardiacmagneticresonanceforthediagnosisofhypertrophiccardiomyopathy AT turillazziemanuela postmortemcardiacmagneticresonanceforthediagnosisofhypertrophiccardiomyopathy AT dipaolomarco postmortemcardiacmagneticresonanceforthediagnosisofhypertrophiccardiomyopathy |